Reply to the article “Editorial comment on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’”, by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339–1340)

V.C.G Tjan-Heijnen,P.E Postmus,A Ardizzoni

doi:10.1093/annonc/mdf138

Reply to the article “Editorial comment on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’”, by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339–1340)

V.C.G Tjan-Heijnen, P.E Postmus + Show 1 more

Open Access

https://doi.org/10.1093/annonc/mdf138

Copy DOI

Journal: Annals of Oncology	Publication Date: Mar 1, 2002
Citations: 3	License type: publisher-specific-oa

Affiliation: Vrije Universiteit Amsterdam

#Febrile Leucopenia #Use Of Antibiotics + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Reply to the article “Editorial comment on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’”, by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339–1340)

Full Text